Today, Copenhagen Infrastructure Partners (CIP) announced that its fifth flagship fund, CI V, surpasses its target size of EUR 12 billion at final close. COPENHAGEN, Denmark, March 14, 2025 (GLOBE NEWSWIRE) — Investor interest in large-scale greenfield energy infrastructure investments is strong, and CIP is now finalising fundraising for CI V with total fund commitments exceeding the target of EUR 12 billion, excluding capital raised for co-investments. “Reaching 12 billion euros is a fantastic result and a testament to our proven industrial approach to energy infrastructure investments. I am proud that several of the world’s largest and most sophisticated investors

HONG KONG SAR – Media OutReach Neswire – 14 March 2025 – Hong Kong has emerged as the world’s “most improved” location for university degree courses, reflecting the determination of the Hong Kong Special Administrative Region (HKSAR) Government to develop the city into an international education hub with strong emphasis on nurturing talents in innovation and technology. The 2025 QS World University Rankings by Subject rated six local degree courses among the world’s top 10, up from three last year, while 68% of 231 programmes from nine Hong Kong institutions rose in the rankings. In the field of data science and artificial

KYP IATA Facephi digital Identity seamless travel MADRID, March 12, 2025 (GLOBE NEWSWIRE) — Facephi, a leading company in digital identity technology, has reinforced its commitment to transforming the aviation sector at the IATA World Data Symposium. At this key industry event, the company showcased several solutions aimed at enabling a fully digital air travel experience, aligning with IATA’s One ID initiative, which seeks to eliminate airport frictionless through verifiable credentials and facial biometrics. Currently, passengers must verify their identity at multiple checkpoints throughout a single journey, leading to delays and increased congestion at airports. To address this challenge, Facephi

REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results FDA PMA Application Review Nearing Conclusion Positioned for U.S. Commercial Launch in March 2025 Mont-Saint-Guibert, Belgium – March 13, 2024, 7:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today reported financial and operating results for the fourth quarter and financial year 2024. Recent Financial and Operating Highlights Revenue for the fourth quarter of 2024 was €1.3 million, which excludes €0.6 million of deferred revenue Revenue for the full year 2024 was €4.5 million, which excludes €0.6 million of deferred revenue Gross margin for the fourth quarter of 2024 was 73% At December 31, 2024, cash and financial assets were €85.6 million, compared to €57.7 million at December 31, 2023 Assembled U.S. executive leadership team with deep industry experience Full U.S. commercial organization, including sales, marketing, and market